Kaye Competition
The Kaye Competition is a partnership between the University of Alberta Hospital (UAH), Kaye Edmonton Clinic (KEC) and the University Hospital Foundation (UHF), made possible through a $30 million transformational donation from Mr. Donald Kaye to UHF in 2012. This gift is one of the largest donations in the history of Canadian healthcare philanthropy.
Project budgets can range from $25,000 to $250,000
The Kaye Competition is made possible thanks to a $30 million gift from Mr. Donald Kaye
75% of funding is restricted to cancer, pulmonary, diabetes and neurology.
Competition criteria
The Kaye Competition supports individuals or collaborative, interdisciplinary, and multidisciplinary teams in the pursuit of research, innovation, and quality improvement programs and projects that will establish new approaches to patient care.
Applicants may include physicians, nurses, and allied health staff of the University of Alberta Hospital (UAH) or Kaye Edmonton Clinic (KEC), students or researchers in health disciplines from another faculty through joint application with an affiliate of the UAH or KEC. The research or quality improvement program or project must be conducted at the UAH/KEC or directly impact the care of patients at these sites.
Application and review process
Step 1
Download and review the guidelines. (Download PDF)
Step 2*
Visit https://uhf-apply.smapply.ca/ to apply and submit your Letter of Intent (LOI). Deadline for submission of LOI is November 17th, 2023 at 4:00 p.m. MST
Step 3
Steering Committee review and evaluate applications.
Step 4*
Successful LOI applicants will be notified and invited to submit Full Proposals. Deadline for submission of Full Proposal is March 29th, 2024 at 4:00 p.m. MST
Step 5
Competition winners will be notified in July 2024.
* Internal organizational consultation deadline applies – see guidelines for details
2022 Kaye Competition Awardees
- Understanding the Impact of Immunotherapy on Bone Health in Immunotherapy Survivors: from Bench to Patient to Population (Dr. Carrie Ye)
- The Accuracy and Usability of Different Glucose Measurement Methods During Surgery: A Patient-Driven Comparative Analysis (Dr. Derek Dillane)
- Point-of-Care Ultrasound of the Diaphragm in Amyotrophic Lateral Sclerosis as a Novel Predictor of Respiratory Failure and Disease Progression (Dr. Grayson Beecher)
- Towards Improved Bladder Cancer Detection: Recruitment of Patients at the Kaye Edmonton Clinic for a Novel Predictive Biomarker Test (Dr. John Lewis)
- De-Adoption of β-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a pragmaTic randomizEd trial (The AβBREVIATE Trial) (Dr. Sean van Diepen)